| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.041 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.034 | 0.9 |